Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Colorectal Neoplasms × Calcium × Clear all

Phase

Phase NA 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Osteoporosis 2 Breast Neoplasms 2 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Disease Progression 1 Colorectal Neoplasms 1 Bone Diseases, Metabolic 1

Interventions

Fluorouracil 108 Leucovorin 101 Oxaliplatin 77 Bevacizumab 69 Irinotecan 60 Capecitabine 57 Cetuximab 34 Folfox protocol 28 Panitumumab 15 regorafenib 13 Drug Therapy 13 trifluridine tipiracil drug combination 12 Chemotherapy, Adjuvant 11 IFL protocol 9 Radiotherapy 8 Floxuridine 8 Neoadjuvant Therapy 7 Aspirin 7 pembrolizumab 5 XELOX 5 Levoleucovorin 5 Laparoscopy 5 dehydroftorafur 4 atezolizumab 4 Trifluridine 4 S 1 (combination) 4 Octreotide 4 Mitomycin 4 Magnetic Resonance Spectroscopy 4 Celecoxib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01087658 2013-06-21

GLUTOX

Sanofi

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡